Translational Breast Cancer Research,
Год журнала:
2023,
Номер
4, С. 21 - 21
Опубликована: Июль 1, 2023
Breast
cancer
is
the
most
commonly
diagnosed
and
second
leading
cause
of
cancerrelated
death
in
women,
accounting
for
approximately
30%
all
new
cases.The
prognosis
breast
heavily
depends
on
stage
diagnosis,
with
early
detection
resulting
higher
survival
rates.Various
risk
factors,
including
family
history,
alcohol
consumption
hormone
exposure,
contribute
to
development.Triple-negative
(TNBC),
characterized
by
absence
certain
receptors,
particularly
aggressive
heterogeneous.Cerebral
cavernous
malformations
(CCMs),
abnormal
dilations
small
blood
vessels
brain,
contributed
mutated
genes
like
CCM1,
CCM2,
CCM3
through
perturbed
formation
CCM
signaling
complex
(CSC).The
CSC-non-classic
membrane
progesterone
receptors
(mPRs)-progesterone
(PRG)
(CmP)/CSC-mPRs-PRG-classic
nuclear
(nPRs)
(CmPn)
network,
which
integrates
CSC
mPRs
nPRs,
plays
a
role
tumorigenesis.Understanding
these
pathways
can
provide
insights
into
potential
treatments.This
paper
focuses
emerging
field
CmPn/CmP
signal
networks,
involve
PRG,
its
(nPRs
mPRs),
CSC.These
networks
play
tumorigenesis,
TNBCs.Aims
deliver
thorough
examination
CmP/CmPn
concerning
TNBCs,
this
provides
comprehensive
overview
pathways,
explores
their
applications
highlights
significance
context
TNBCs.
Pharmaceutics,
Год журнала:
2023,
Номер
15(7), С. 1796 - 1796
Опубликована: Июнь 23, 2023
Triple
negative
breast
cancer
(TNBC)
has
a
expression
of
estrogen
receptors
(ER),
progesterone
(PR),
and
human
epidermal
growth
factor
(HER2).
The
survival
rate
for
TNBC
is
generally
worse
than
other
subtypes.
treatment
made
significant
advances,
but
certain
limitations
remain.
Treatment
can
be
challenging
since
the
disease
various
molecular
A
variety
options
are
available,
such
as
chemotherapy,
immunotherapy,
radiotherapy,
surgery.
Chemotherapy
most
common
these
options.
treated
with
systemic
chemotherapy
using
drugs
anthracyclines
taxanes
in
neoadjuvant
or
adjuvant
settings.
Developing
resistance
to
anticancer
off-target
toxicity
primary
hindrances
chemotherapeutic
solutions
cancer.
It
imperative
that
researchers,
clinicians,
pharmaceutical
companies
work
together
develop
effective
TNBC.
Several
studies
have
suggested
nanotechnology
potential
solution
problem
suboptimal
treatment.
In
this
review,
we
summarized
possible
TNBC,
including
targeted
therapy,
combination
nanoparticle-based
some
future.
Moreover,
gave
general
information
about
terms
its
characteristics
aggressiveness.
Foods,
Год журнала:
2024,
Номер
13(11), С. 1774 - 1774
Опубликована: Июнь 5, 2024
Curcumin,
a
hydrophobic
polyphenol
extracted
from
the
rhizome
of
Curcuma
longa,
is
now
considered
candidate
drug
for
treatment
neurological
diseases,
including
Parkinson’s
Disease
(PD),
Alzheimer’s
(AD),
Huntington’s
(HD),
Multiple
Sclerosis
(MS),
Amyotrophic
Lateral
(ALS),
and
prion
disease,
due
to
its
potent
anti-inflammatory,
antioxidant
potential,
anticancerous,
immunomodulatory,
neuroprotective,
antiproliferative,
antibacterial
activities.
Traditionally,
curcumin
has
been
used
medicinal
dietary
purposes
in
Asia,
India,
China.
However,
low
water
solubility,
poor
stability
blood,
high
rate
metabolism,
limited
bioavailability,
little
capability
cross
blood–brain
barrier
(BBB)
have
clinical
application
curcumin,
despite
important
pharmacological
activities
this
drug.
A
variety
nanocarriers,
liposomes,
micelles,
dendrimers,
cubosome
nanoparticles,
polymer
solid
lipid
nanoparticles
developed
with
great
success
effectively
deliver
active
brain
cells.
Functionalization
on
surface
brain-specific
ligands
makes
them
target-specific,
which
should
significantly
improve
bioavailability
reduce
harmful
effects.
The
aim
review
summarize
studies
and/or
containing
most
common
neurodegenerative
highlighting
neuroprotective
potential
nutraceutical.
Abstract
Breast
cancer
is
a
complex
and
heterogeneous
disease,
encompassing
various
subtypes
characterized
by
distinct
molecular
features,
clinical
behaviors,
treatment
responses.
Categorization
of
based
on
the
presence
or
absence
estrogen
receptor
(ER),
progesterone
(PR),
human
epidermal
growth
factor
2
(HER2),
leading
to
such
as
luminal
A,
B,
HER2-positive,
triple-negative
breast
(TNBC).
TNBC,
comprising
around
20%
all
cancers,
lacks
expression
ER,
PR,
HER2
receptors,
rendering
it
unresponsive
targeted
therapies
presenting
significant
challenges
in
treatment.
TNBC
associated
with
aggressive
behavior,
high
rates
recurrence,
resistance
chemotherapy.
Tumor
initiation,
progression,
are
attributed
stem
cells
(BCSCs),
which
possess
self-renewal,
differentiation,
tumorigenic
potential.
Surface
markers,
self-renewal
pathways
(Notch,
Wnt,
Hedgehog
signaling),
apoptotic
protein
(Bcl-2),
angiogenesis
inhibition
(VEGF
inhibitors),
immune
modulation
(cytokines,
checkpoint
inhibitors)
among
key
targets
discussed
this
review.
However,
targeting
BCSC
subpopulation
presents
challenges,
including
off-target
effects,
low
solubility,
bioavailability
anti-BCSC
agents.
Nanoparticle-based
offer
promising
approach
target
cellular
processes
implicated
survival
BSCS
TNBC.
In
review,
we
explore
nanocarrier-based
approaches
for
BCSCs
aiming
overcome
these
improve
outcomes
patients.
These
nanoparticle-based
therapeutic
strategies
hold
promise
addressing
gap
delivering
while
minimizing
systemic
toxicity
enhancing
efficacy.
Graphical
abstract
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(23), С. 14937 - 14937
Опубликована: Ноя. 29, 2022
Heterogeneity
of
triple-negative
breast
cancer
is
well
known
at
clinical,
histopathological,
and
molecular
levels.
Genomic
instability
greater
mutation
rates,
which
may
result
in
the
creation
neoantigens
enhanced
immunogenicity,
are
additional
characteristics
this
type.
Clinical
outcome
poor
due
to
early
age
onset,
high
metastatic
potential,
increased
likelihood
distant
recurrence.
Consequently,
efforts
elucidate
mechanisms
development,
progression,
spread
have
been
initiated
improve
treatment
options
outcomes
for
these
patients.
The
extremely
complex
heterogeneous
tumor
immune
microenvironment
made
up
several
cell
types
commonly
possesses
disorganized
gene
expression.
Altered
signaling
pathways
mainly
associated
with
mutated
genes
including
p53,
PIK3CA,
MAPK,
positively
correlated
regulating
response.
Of
note,
particular
immunity-associated
could
be
used
prognostic
indexes
assess
most
effective
management.
Recent
findings
highlight
fact
that
long
non-coding
RNAs
also
play
an
important
role
shaping
formation,
can
mediate
evasion.
Identification
signatures,
through
use
multi-omics
approaches,
effector
drive
stages
carcinogenic
process
steps
developing
new
strategies
targeted
prevention.
Advances
immunotherapy
by
remodeling
host
system
eradicate
cells
great
promise
lead
novel
therapeutic
strategies.
Current
research
focused
on
combining
checkpoint
inhibition
chemotherapy,
PARP
inhibitors,
vaccines,
or
natural
killer
therapy.
Targeted
therapies
response,
eliminate
resistance,
overall
patient
survival.
In
future,
evolving
advancements
should
implemented
personalized
medicine
state-of-art
management
Antibiotics,
Год журнала:
2022,
Номер
11(6), С. 735 - 735
Опубликована: Май 30, 2022
Triclosan
(TCS),
a
broad-spectrum
antimicrobial
agent,
has
been
widely
used
in
personal
care
products,
medical
plastic
cutting
boards,
and
food
storage
containers.
Colgate
Total®
toothpaste,
containing
10
mM
TCS,
is
effective
controlling
biofilm
formation
maintaining
gingival
health.
Given
its
broad
usage,
TCS
present
ubiquitously
the
environment.
strong
lipophilicity
accumulation
ability
organisms,
it
potentially
harmful
to
biohealth.
Several
reports
suggest
toxicity
of
this
compound,
which
inserted
class
endocrine
disrupting
chemicals
(EDCs).
In
September
2016,
was
banned
by
U.S.
Food
Drug
Administration
(FDA)
European
Union
soap
products.
Despite
these
problems,
application
products
within
certain
limits
still
allowed.
Today,
unclear
whether
truly
toxic
mammals
adverse
effects
continuous,
long-term,
low
concentration
exposure
remain
unknown.
Indeed,
some
recent
use
as
repositioned
drug
for
cancer
treatment
cutaneous
leishmaniasis.
scenario
necessary
investigate
advantages
disadvantages
understand
advisable
or
not.
This
review
intends
highlight
pros
cons
that
are
associated
with
humans.
Biology,
Год журнала:
2023,
Номер
12(10), С. 1335 - 1335
Опубликована: Окт. 16, 2023
Cobalt
(Co)
is
an
essential
trace
element
for
humans
and
other
animals,
but
high
doses
can
be
harmful
to
human
health.
It
present
in
some
foods
such
as
green
vegetables,
various
spices,
meat,
milk
products,
seafood,
eggs,
drinking
water.
Co
necessary
the
metabolism
of
beings
animals
due
its
key
role
formation
vitamin
B12,
also
known
cobalamin,
biological
reservoir
Co.
In
concentrations,
may
cause
health
issues
vomiting,
nausea,
diarrhea,
bleeding,
low
blood
pressure,
heart
diseases,
thyroid
damage,
hair
loss,
bone
defects,
inhibition
enzyme
activities.
Conversely,
deficiency
lead
anorexia,
chronic
swelling,
detrimental
anemia.
nanoparticles
have
different
biomedical
applications
thanks
their
antioxidant,
antimicrobial,
anticancer,
antidiabetic
properties.
addition,
cobalt
oxide
used
lithium-ion
batteries,
a
catalyst,
carrier
targeted
drug
delivery,
gas
sensor,
electronic
thin
film,
energy
storage.
Accumulation
agriculture
humans,
natural
anthropogenic
factors,
represents
global
problem
affecting
water
quality
animal
Besides
common
chelating
agents
intoxication,
phytoremediation
interesting
environmental
technology
cleaning
up
soil
contaminated
with
The
occurrence
environment
discussed
involvement
processes
underlined.
Toxicological
aspects
related
are
examined
this
review.
Triple
negative
breast
cancer
(TNBC)
has
a
expression
of
estrogen
receptors
(ER),
progesterone
(PR),
or
human
epidermal
growth
factor
(HER2).
The
survival
rate
for
TNBC
is
generally
worse
than
other
subtypes.
treatment
made
significant
advances,
but
certain
limitations
remain.
Treatment
can
be
challenging
since
the
disease
various
Individualized
therapy
recommended
rather
generalized
therapy,
given
genetic
variations
among
these
A
precise
and
effective
requires
identifying
prognostic
markers.
Depending
on
type
stage
TNBC,
patients
are
treated
with
therapeutic
interventions.
variety
options
available,
such
as
chemotherapy,
immunotherapy,
radiotherapy,
surgery.
Chemotherapy
most
common
options.
systemic
chemotherapy
using
drugs
anthracyclines
taxanes
in
neoadjuvant
adjuvant
settings.
Developing
resistance
to
anticancer
off
target
toxicity
primary
hindrances
chemotherapeutic
solutions
cancer.
It
imperative
that
researchers,
clinicians,
pharmaceutical
companies
work
together
develop
TNBC.
Several
studies
have
suggested
nanotechnology
potential
solution
problem
suboptimal
treatment.
Foods,
Год журнала:
2022,
Номер
11(18), С. 2884 - 2884
Опубликована: Сен. 17, 2022
The
beginning
of
the
end
or
beginning?
After
two
years
mastered
by
coronavirus
disease
19
(COVID-19)
pandemic,
we
are
now
witnessing
a
turnaround.
reduction
severe
cases
and
deaths
from
COVID-19
led
to
increasing
importance
new
called
post-COVID
syndrome.
term
is
used
indicate
permanency
symptoms
in
patients
who
have
recovered
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection.
Immune,
antiviral,
antimicrobial
therapies,
as
well
ozone
therapy
been
treat
disease.
Vaccines
then
become
available
administered
worldwide
prevent
insurgence
However,
pandemic
not
over
yet
at
all
given
emergence
omicron
variants.
New
therapeutic
strategies
urgently
needed.
In
this
view,
great
interest
was
found
nutraceutical
products,
including
vitamins
(C,
D,
E),
minerals
(zinc),
melatonin,
probiotics,
flavonoids
(quercetin),
curcumin.
This
review
summarizes
role
nutraceuticals
prevention
and/or
treatment
Applied Sciences,
Год журнала:
2023,
Номер
13(10), С. 6045 - 6045
Опубликована: Май 15, 2023
The
cytochrome
P450
(CYP)
enzyme
family
is
the
major
system
catalyzing
phase
I
metabolism
of
xenobiotics,
including
pharmaceuticals
and
toxic
compounds
in
environment.
A
part
CYP-dependent
xenobiotic
due
to
polymorphic
inducible
enzymes,
which
may,
quantitatively
or
qualitatively,
alter
enhance
drug
toxicity.
Drug–drug
interactions
are
mechanisms
caused
by
inhibition
and/or
induction
CYP
enzymes.
Particularly,
monooxygenases
catalyze
hydroxylation
reactions
form
hydroxylated
metabolites.
secondary
metabolites
sometimes
as
active
parent
compound,
even
more
active.
aim
this
review
summarize
some
significative
examples
common
drugs
used
for
treatment
diverse
diseases
underline
activity
toxicity
their